ALX Oncology Holdings Inc. (ALXO) Tops Q3 EPS by 20c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q3 EPS of ($0.58), $0.20 better than the analyst estimate of ($0.78).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
• Gold.com (GOLD) call put ratio 2.4 calls to 1 put into quarter results
• PVH Corp. (PVH) call put ratio 1.4 calls to 1 put into quarter results